SCHEMBL25754033

SCHEMBL25754033

COP(=O)(O)OC[C@H]1O[C@@H](n2cnc3c(N)ncnc32)CC1OCS

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ POLB P06746 1/20 0.58
▸ P2RY1 P47900 5/20 0.55
▸ ENPP1 P22413 2/20 0.55
▸ P2RY2 P41231 3/20 0.54
▸ P2RX1 P51575 3/20 0.54
▸ P2RX3 P56373 3/20 0.54
▸ SRC P12931 2/20 0.54
▸ SMN1; SMN2 Q16637 2/20 0.54
▸ P2RX4 Q99571 2/20 0.54
▸ P2RX2 Q9UBL9 2/20 0.54
▸ ALDH1A1 P00352 1/20 0.54
▸ DTYMK P23919 2/20 0.53
▸ DNPH1 O43598 1/20 0.53
▸ PRKAB2 O43741 1/20 0.53
▸ TRPM2 O94759 1/20 0.53
▸ LDHA P00338 1/20 0.53
▸ ADRB2 P07550 1/20 0.53
▸ FBP1 P09467 1/20 0.53
▸ ADORA1 P30542 1/20 0.53
▸ PRKAG1 P54619 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25766886 0.92 P2RY1 (0.62) POLBP2RY1ENPP1P2RY2SRC
SCHEMBL16695892 0.91 POLB (0.59) POLBP2RY1ENPP1P2RY2P2RX1
SCHEMBL25786818 0.91 POLB (0.59) POLBP2RY1ENPP1P2RY2P2RX1
SCHEMBL26068420 0.91 POLB (0.59) POLBP2RY1ENPP1P2RY2P2RX1
SCHEMBL17122140 0.90 POLB (0.58) POLBP2RY1ENPP1P2RY2P2RX1
SCHEMBL18745523 0.89 POLB (0.54) POLBP2RY1ENPP1P2RY2P2RX1
SCHEMBL17122136 0.88 POLB (0.56) POLBP2RY1ENPP1P2RY2P2RX1
SCHEMBL16248673 0.87 POLB (0.74) POLBP2RY1ENPP1P2RY2P2RX1
SCHEMBL19051966 0.87 POLB (0.74) POLBP2RY1ENPP1P2RY2P2RX1
SCHEMBL24325561 0.87 POLB (0.53) POLBP2RY1ENPP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230203083-A1 NUCLEOTIDE ANALOGUES FIRST-CITIZENS BANK & TRUST COMPANY 2023-06-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230203083-A1 NUCLEOTIDE ANALOGUES ITPA, POLB, NUDT1 POLB 2/4885P2RY1 1172/4885ENPP1 85/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback